Brand: Innovita FDA CE German lots of country approval and certs
Taiwan Made AntiBody Rapid Test Kit Brand: Alert FDA CE 10 kits per box MOQ: 100 boxes
BIOMETRO is an in-vitro diagnostic device manufacturer serving to improve the health and well-being of people around the world. Our effort for the development of medical IVD device based on proprietary Cathodic Electrochemiluminescence (C-ECL) technology, resulted in better clinical and personal healthcare outcomes globally
RAPID ANTIBODY/Finger Prick 10 to 15 Minute Results An antibody test is also known as a serology test looks for the presence of antibodies, which are specific proteins made in response to infections. It is effective at detecting the recent past SARS-CoV2 infection. This test can detect the body's IgM Antibody response in as little as 7 days (IgG in 14 days) from infection with CDC validated 100% specificity and 100% sensitivity. The highest accuracy serological test on the market FDA EUA Approved Manufactured by one of the leaders in lateral flow technology Results in 10-15 minutes FINGER PRICK NO LAB RESULTS REQUIRED
This kit is used for in vitro qualitative detection of SARS-CoV-2 antigen. It is a lateral flow sandwich test designed for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) and nasal (NS) swab specimens. Type: VISION Covid-19 Rapid Antigen CE-IVD Test Kiti Sample Types: Sputum, Nasopharyngeal swab, Oropharyngeal swab Sensitivity Ratio: Sensitivity : %96,66 , Specifity : %98,96 Contents: Swab, kyro tube, lyss buffer, Silica jel, Alkollu Swab, Test kaseti Number of Kits in a Box: 15 test Storage condition: Room temperature Shipping Type: Shipping storage condition Room temperature Analysis Time: 15 Min
Real time cloud app based Covid 19 POC RDTs capable of testing IgG-IgM-Ag combo within 10 minutes which is barcoded with the ability to use any camera based smart phone to transmit results which can be tracked any where irrespective of location. Can deployed for airport arrival-departure terminals, boarders, schools, prisons, churches, factories, industries, remote areas and more. Package includes: Test kit Software Database user license Management reports Data analytics We also have other tests portfolios such as HIV, Malaria, hepatitis, typhoid IgG-IgM, G6PD, Hb electrophoresis and many more.
We have the best quantity covid-19 self-test kit antigens wholesale available and the best prices
2019-nCoV Antigen Rapid Test Kit (Colloidal gold Assay) Specimen Type: Siliva Time to result: 15 minutes quick test Storage: 18 months (room temperature) Package: 25 Tests/Box ( 25 test cassettes + 25 Antigen extraction tubes + 25 Saliva sampling cups+ 25 Sampling droppers + 1 bottle Antigen extract R1 buffer+ 1 Test tube stand + 1 manual) Relative Sensitivity: 90.3%. New products will be launced in next 2 weeks, please mantain your attention! 2019-nCoV Antigen Rapid Test Kit (Colloidal gold Assay) Specimen Type: Nasopharyngeal Swab Time to result: 15 minutes quick test Storage: 18 months (room temperature) Package: 25 Tests/Box (25 pcs Nasopharyngeal swab + 25 test cassettes + 1 bottle Antigen extraction tube + 1 bottle Antigen extract R1) Relative Sensitivity: >85% Short test time: Within 15 Minutes Accuracy: More than 90% Easy operation: Throat/Nose swab, Saliva sample. One-step solution - Lower cost with high efficiency Components: A 25 test cassettes B 25 Antigen extraction tubes C 1 bottle antigen extract R1 D 1 Test tube stand E 25pcs Saliva Sample cups F 25pcs disposable droppers G 1 manual Application: A Suspected case test in epidemic area B Early test of fever clinic and CDC C Screening of primary medical institutions D Inspection of floating population in public areas Product Information: Product Name : 2019-nCoV Antigen Rapid Test Kit Methodology : Colloidal Gold Assay Size: 25 Tests/box Storage and Validity: Stored at 2-30 within 18 months Specimen: Nasopharyngeal Saliva Read the results in 15 minutes. A strong positive results may show within 15 minute. But the negative result must be reported after 15 minutes. And the results after 20 minutes are not valid anymore.
100 Percent USA Made FDA EAU and CE approved rapid Antigen and Antibody test kits.
This is Product is very demand due to pandamic situation. We are supplying ICMR approved ,CE certified product
SARS-CoV-2 IgG/IgM Rapid Test Kit Intended Use: To detect IgM and IgG antibodies against N and S protein of SARS-CoV-2 in whole blood, serum and plasma Product Format: 25 tests/kit Kit Contents: test card, diluent, capillary, lancet, and instruction for use. Storage/Stability: 2 C to 30C for 12 months.� eproducibility /Precision 100% Concordant across 3 lots with CV ±5% Performance Comparison (A) China Validation Test Positive Samples 100 / 102 Sensitivity: 98.04% Negative Samples 491/492 Specificity: 99.80% Overall Accuracy: 99.49% Performance Comparison (B) Positive Samples 23 / 25 Sensitivity: 92% Negative Samples 25 / 25 Specificity: 100% Overall Accuracy: 96%
20 tests/box
covid antigen nasal rapid test passed the Germany PEI testing and registered on EU Common List
20 tests/box, 1 pcs/box, 5pcs/box
Viral transport medium is used to carry the patient samples to test in RTPCR testing.
For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For in vitro diagnostic use only. For professional use only .
1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
The performance of SARS-CoV-2 Antigen Rapid Test NOTE:Sign a contract with the distributor. If you want to sign a contract with the factory, please don't ask, Payment method : escrow bank,LC(Less than $350000ï¼? Welcome real buyers,Orders can be tested in small batches
The PocRoc SARS-CoV-2 Neutralizing Antibody Rapid Test Kit is developed for in vitro qualitative detection of SARS-CoV-2 neutralizing antibodies in human serum, plasma, or whole blood samples. SARS-CoV-2 Neutralizing antibody is an important marker for assessing the effectiveness of the SARS-CoV-2 vaccines. The reagent is for neutralizing antibody detection in samples from individuals after vaccine injection or recovered from COVID-19. PocRoc�® SARS-CoV-2 Neutralizing Antibody Rapid Test Kit has great significance for the development of SARS-CoV-2 vaccines, evaluation of effectiveness, and evaluation of neutralizing antibody levels in human bodies. For Medical Professional Use Only! TEST PROCEDURE Do not open the sealing strip until you are ready to perform a test, and the single-use test is suggested to be used under a low environment humidity (RHâ?¤70%) within 1 hour. 1. Allow all the components of the kit and specimens to reach room temperature prior to testing. 2. Take out the test card and place it on a clean dry surface. 3. Identify the test card for each specimen. 4. Use a dropper to deliver one drop (~40�¼l) of serum, plasma, or whole blood samples into the sample well on the test card, followed by one drop (~40l) of sample buffer. 5. Start the timer and read the result immediately after 15 minutes, and the result after 30 minutes is invalid.
